GCG genetic expansions in Italian patients with oculopharyngeal muscular dystrophy

Neurology

Volumn 54, Issue 3, 2000, Pages 608-614

  Mirabella, M ^b   Silvestri, G ^b   De Rosa, G ^b   Di Giovanni, S ^b   Di Muzio, A ^b   Uncini, A ^b   Tonali, P ^b   Servidei, Serenella ^a  

^a CATHOLIC UNIVERSITY   (Italy)

^b NONE

Author keywords

GCG expansions; Oculopharyngeal muscular dystrophy; Poly(A) binding protein 2 gene (PABP2); Trinucle otide repeat

Indexed keywords

BINDING PROTEIN; POLY(A) BINDING PROTEIN 2; POLYADENYLIC ACID; UNCLASSIFIED DRUG;

ADULT; AGED; ALLELE; ARTICLE; CHROMOSOME 14Q; CLINICAL ARTICLE; CONTROLLED STUDY; DYSPHAGIA; FEMALE; GENE MUTATION; GENETIC SCREENING; HUMAN; HUMAN TISSUE; ITALY; MALE; MUSCLE BIOPSY; MUSCLE WEAKNESS; NUCLEOTIDE SEQUENCE; OCULOPHARYNGEAL MUSCULAR DYSTROPHY; PRIORITY JOURNAL; PTOSIS; TRINUCLEOTIDE REPEAT;

EID: 0034620564     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/wnl.54.3.608     Document Type: Article

References (29)

1. Tomé FMS, Fardeau M. Oculopharyngeal muscular dystrophy. In: Engel AG, Franzini-Armstrong C, eds. Myology, 2nd ed. New York: McGraw-Hill, 1994;1233-1245.
2. Tomé FMS, Fardeau M. Nuclear inclusions in oculopharyngeal dystrophy. Acta Neuropathol 1980;49:85-87.
3. Tomé FMS, Chateau D, Helbling-Leclerc A, Fardeau M. Morphological changes in muscle fibers in Oculopharyngeal muscular dystrophy. Neuromuscul Disord 1997;7(suppl 1):63-69.
4. Dubowitz V, Brooke MH. Muscle biopsy: a modern approach. Philadelphia: Saunders, 1973;231-241.
5. Askanas V, Engel WK. New advances in the understanding of sporadic inclusion-body myositis and hereditary inclusion-body myopathies. Curr Opin Rheumatol 1995;7:486-496.
6. Fukuhara N, Kumamoto T, Tsubaki T. Rimmed vacuoles. Acta Neuropathol 1980;51:229-235.
7. Brais B, Xie YG, Sanson M, et al. The oculopharyngeal muscular dystrophy locus maps to the region of the cardiac α and β myosin heavy chain genes on chromosome 14q1.2-q13. Hum Mol Genet 1995;4:429-434.
8. Brais B, Bouchard JP, Xie YG, et al. Short GCG expansions in the PABP2 gene cause oculopharyngeal muscular dystrophy. Nat Genet 1998;18:164-167.
9. Krause S, Fakan S, Weis K, Wahle E. Immunodetection of poly(A)-binding protein II in cell nucleus. Exp Cell Res 1994; 214:75-82.
10. Wahle E. A novel poly(A)-binding protein acts as a specificity factor in the second phase of messenger RNA polyadenylation. Cell 1991;66:759-768.
11. Davies SW, Turmaine M, Cozens BA, et al. Formation of intranuclear inclusions underlies the neurological dysfunctions in mice transgenic for the HD mutation. Cell 1997;90:537-548.
12. DiFiglia M, Sapp E, Chase KO, et al. Aggregation of Huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain. Science 1997;277:1990-1993.
13. Paulson HL, Perez MK, Trottier Y, et al. Intranuclear inclusions of expanded polyglutamine protein in spinocerebellar ataxia type 3. Neuron 1997;19:333-344.
14. Brais B, Morgan K, Xie Y, et al. Strong linkage disequilibrium suggests one founder mutation is responsible for all cases of oculopharyngeal muscular dystrophy in the French Canadian population. Am J Hum Genet 1995;57:A160.
15. Brunet G, Tomé FMS, Eymard B, Robert JM, Fardeau M. Genealogical study of oculopharyngeal muscular dystrophy in France. Neuromuscul Disord 1997;7(suppl 1):34-37.
16. Stajich JM, Gilchrist JM, Lennon F, et al. Confirmation of linkage of oculopharyngeal muscular dystrophy to chromosome 14q11.2-q13 in American families suggests the existence of a second causal mutation. Neuromuscul Disord 1997; 7(suppl 1):75-81.
17. Servidei S. Mitochondrial encephalomyopathies: gene mutation. Neuromusc Disord 1999;9:15-22.
18. Sambrook J, Fritsch EF, Maniatis T. Molecular cloning: a laboratory manual. 2nd edition. Cold Spring Harbor Laboratory Press, 1989.
19. Victor M, Hayes R, Adams RD. Oculopharyngeal muscular dystrophy: a familial disease of late life characterized by dysphagia and progressive ptosis of the eyelids. N Engl J Med 1962;267:1267-1272.
20. Taylor EW. Progressive vagus-glossopharyngeal paralysis with ptosis: a contribution to the group of family diseases. J Nerv Ment Dis 1915;42:129-139.
21. Hardiman O, Halperin JJ, Farrel MA, et al. Neuropathic findings in oculopharyngeal muscular dystrophy. Report of seven cases and review of the literature. Arch Neurol 1993;50:481-488.
22. Bouchard JP, Brais B, Brunet D, Gould PV, Rouleau GA. Recent studies on oculopharyngeal muscular dystrophy in Quebec. Neuromuscul Disord 1997;7(suppl 1):22-29.
23. Rebeiz JJ, Caulfield JB, Adams RD. Oculopharyngeal dystrophy-a presenescent myopathy. A clinico-pathologic study. In: Brunette JR, Barbeau A, eds. Progress in neuro-ophthalmology, vol. 2. Amsterdam: Excerpta Medica, ICS no. 176, 1969:12-31.
24. Little BW, Perl DP. Oculopharyngeal muscular dystrophy. An autopsied case from the French-Canadian kindred. J Neurol Sci 1982;53:145-158.
25. Schmitt HP, Krause KH. An autopsy study of a familial oculopharyngeal muscular dystrophy (OPMD) with distal spread and neurogenic involvement. Muscle Nerve 1981;4:296-305.
26. Probst A, Tackmann W, Stoeckli HR, Jerusalem F, Ulrich J Evidence for a chronic axonal atrophy in oculopharyngeal "muscular dystrophy". Acta Neuropathol 1982;57:209-216.
27. Rose MR, Landon DN, Papadimitriou A, Morgan-Hughes JA. A rapidly progressive adolescent-onset oculopharyngeal somatic syndrome with rimmed vacuoles in two siblings. Ann Neurol 1997;41:25-31.
28. Porschke H, Kress W, Reichmann H, Goebel HH, Grimm T. Oculopharyngeal muscular dystrophy in a northern German family linked to chromosome 14q, and presenting carnitine deficiency. Neuromuscul Disord 1997;7(suppl 1):57-62
29. Davies S, Beardsall K, Turmaine M, DiFiglia M, Aronin N, Bates GP. Are neuronal intranuclear inclusions the common neuropathology of triplet-repeat disorders with polyglutamine-repeat expansions? Lancet 1998;351:131-133.